missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human CCL8/MCP-2 Antibody, R&D Systems™

Goat Polyclonal Antibody
Brand: R&D Systems AF-281-SP
This item is not returnable.
View return policy
Description
CCL8/MCP-2 Polyclonal specifically detects CCL8/MCP-2 in Human samples. It is validated for Western Blot, Neutralization.
Specifications
| CCL8/MCP-2 | |
| Polyclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| C-C motif chemokine 8, chemokine (C-C motif) ligand 8, HC14, MCP2, MCP-2, member 8 (monocyte chemotactic protein 2), monocyte chemoattractant protein 2, SCYA10, small-inducible cytokine A8 | |
| Goat | |
| Affinity Purified | |
| RUO | |
| 6355 | |
| Reconstitute at 0.2 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
| Western Blot, Neutralization | |
| LYOPH | |
| Western Blot 0.1 ug/mL, Neutralization 1.5-5.0 ug/mL | |
| P80075 | |
| CCL8 | |
| E. coli-derived recombinant human CCL8/MCP-2 Gln24-Pro99 Accession # P80075 | |
| 25 μg | |
| Primary | |
| Detects human CCL8/MCP-2 in direct ELISAs and Western blots. In direct ELISAs and Western blots (non-reducing conditions), less than 40% cross-reactivity with recombinant human (rh) HCC-1 is observed, less than 10% cross-reactivity with rhEotaxin is observed, and less than 5% cross-reactivity with rhMCP-1 is observed. Neutralizes the biological activity of rhCCL8. This antibody will not neutralize the biological activity of rhMCP-1, recombinant mouse JE, or rhMCP-3. | |
| Human | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction